Dermatology news & research- Page 4 of 12 | Hospital Healthcare Europe

This website is intended for healthcare professionals only.

Dermatology

Sun awareness measures failing to alter behaviour

Sun awareness measures failing to alter behaviour

Basal cell carcinoma diagnosis improved with novel imaging technique

Basal cell carcinoma diagnosis improved with novel imaging technique

FDA approves ruxolitinib cream for vitiligo

FDA approves ruxolitinib cream for vitiligo

Stopping methotrexate for 2 weeks after COVID-19 vaccination boosts immune response

Stopping methotrexate for 2 weeks after COVID-19 vaccination boosts immune response

Green tea extract decreases severity of radiation-induced dermatitis in breast cancer patients

Green tea extract decreases severity of radiation-induced dermatitis in breast cancer patients

Different emollient formulations appear to be equally effective in childhood eczema

Different emollient formulations appear to be equally effective in childhood eczema

Older adults with atopic eczema at greater risk of developing Alzheimer’s disease

Older adults with atopic eczema at greater risk of developing Alzheimer’s disease

Cochrane systematic review answers only some questions on topical steroids use in eczema

Cochrane systematic review answers only some questions on topical steroids use in eczema

Cardiac biomarkers offer no benefit to CV risk stratification in psoriasis disease

Cardiac biomarkers offer no benefit to CV risk stratification in psoriasis disease

Psoriasis patients self-report higher analgesic usage largely due to joint pain

Psoriasis patients self-report higher analgesic usage largely due to joint pain

$Lirentelimab effective for refractory chronic urticaria$

Lirentelimab effective for refractory chronic urticaria

Tapinarof cream effective for moderately severe plaque psoriasis

Tapinarof cream effective for moderately severe plaque psoriasis

Dupilumab reduces COVID-19 symptom burden in patients with atopic eczema

Dupilumab reduces COVID-19 symptom burden in patients with atopic eczema

Topical asivatrep, a TRPVI antagonist, effective for adults with atopic eczema

Topical asivatrep, a TRPVI antagonist, effective for adults with atopic eczema

Ruxolitinib cream significantly improves patient outcomes in atopic dermatitis

Ruxolitinib cream significantly improves patient outcomes in atopic dermatitis

Chronic urticaria patients at risk of obstructive sleep apnoea

Chronic urticaria patients at risk of obstructive sleep apnoea

NICE approves Cosentyx for children and young people with psoriasis

NICE approves Cosentyx for children and young people with psoriasis

Probiotics reduce risk of developing atopic eczema

Probiotics reduce risk of developing atopic eczema

x